[FORM 10-K þ For the fiscal year ended March 31, 2012 or o For the transition period from ____________________________________ to ________________________________________ 001-34711 CHINA JO-JO DRUGSTORES, INC . (Exact name of issuer as specified in its charter) Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District] [List of Subsidiaries 1. Renovation Investment (Hong Kong) Co., Ltd. (“Renovation”) is a Hong Kong company and is wholly-owned by the Company. 2. Hangzhou Jiutong Medical Technology Co., Ltd. is a Chinese company and is wholly-owned by Renovation. 3. Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. (“Shouantang Technology”) is a Chinese company and is wholly-owned by Renovation. 4. Zhejiang Jiuxin Investment] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-171849) of China Jo-Jo Drugstores, Inc. and subsidiaries of our reports dated July 2, 2012 relating to the consolidated financial statements, which appear in this Form 10-K. New York, New York July 2, 2012 EX-23.1 3] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: 1. I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer July 2, 2012 EX-32.1 6 f10kex32i_chinajojo.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Ming Zhao Chief Financial Officer July 2, 2012 EX-32.2 7 f10kex32ii_chinajojo.htm CERTIFICATION]

[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2012 Earnings Results and schedules conference call for July 3, 2012 Fiscal Year 2012 Highlights: --Revenues reached record $94.4 million --Gross profit rose 30% to $27.6 million, gross margin 29% --Sales from the cultivation of Traditional Chinese Medicines were $4.2 million, from online drug sales was $1.1 million --Net income $8.1 million --Diluted]

[China Jo-Jo Drugstores, Inc. Postpones Fiscal 2012 Conference Call HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail pharmacy chain in Zhejiang and Shanghai, today announced that the Company will postpone its fiscal year 2012 earnings call originally scheduled on Monday, July 2, 2012 at 8 a.m. Eastern Time. The Company will announce the rescheduled time for the]

[China Jo-Jo Drugstores, Inc. Announces Fiscal 2012 Conference Call HANGZHOU, China--(BUSINESS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD), a retail pharmacy chain in Zhejiang and Shanghai, today announced that the Company will hold its fiscal year 2012 earnings call on Monday, July 2, 2012 at 8 a.m. Eastern Time. The Company plans to release earnings on Friday, June 29, 2012 after market]

[CONSULTING SERVICES AGREEMENT Agreement Parties This Consulting Services Agreement (this “ RECITALS (1) Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation; (2) Party B is mainly engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines, cut crude drugs, pharmaceutical chemicals, antibiotics, biochemical] [OPERATING AGREEMENT Ag This Operating Agreement (this “ RECITALS 1. Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation; Business 2. Party B is engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines, cut crude drugs, pharmaceutical chemicals, antibiotics, biochemical drugs, and biological] [VOTING RIGHTS PROXY AGREEMENT Agreement PRC China Party A Party Parties This Voting Rights Proxy Agreement (the “ RECITALS 1. Party A, a company incorporated in the PRC as a foreign invested enterprise, specializes in enterprise management and consultation (collectively the “Business”). Party A and the Company have entered into a certain Consulting Services Agreement dated May 15, 2012 (the] [EQUITY PLEDGE AGREEMENT Agreement PRC China Pledgee Company Pledgor Pledgors Party Parties This Equity Pledge Agreement (hereinafter this “ RECITALS 1. The Pledgee incorporated in the PRC as a foreign invested enterprise and specializes in enterprise management and consultation. 2. Business The Company is engaged in retail of prescription and non-prescription drugs including traditional Chinese medicinal materials, Chinese prepared medicines,] [OPTION AGREEMENT This Option Agreement (this “Agreement”) is dated May 15, 2012, and is entered into in Hangzhou City, People’s Republic of China (“PRC” or “China”) by and among Zhejiang Jiuxin Investment Management Co., Ltd (“Party A”) and Zhejiang Jiuying Grand Pharmacy Co., Ltd. (“Company” or “Party B”), the individual shareholders collectively holding 51% of the issued and outstanding equity] [China Jo-Jo Drugstores Announces New Store Openings in Shanghai and Hangzhou HANGZHOU, China--(BUSINESS WIRE)--May 17, 2012--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail pharmacy chain in Zhejiang and Shanghai, today announced two new store openings in Shanghai and Hangzhou, increasing the Company’s total store count to 61. Three additional stores are planned to be opened in Hangzhou by mid-2012.]